Media Pack
News

Current Edition

Volume 16 Issue 1
 
Australasia

Merck snaps up Australian firm Viralytics for $394M

The deal gives Merck access to Viralytics’s investigational oncolytic immunotherapy Cavatak, that has been shown to preferentially infect and kill cancer cells. &nbs...
27 February 2018 Australasia | news
Continue Reading →
Asia Pacific

US’s PCI Pharma services to acquire Australian packaging firm

The addition of PPP will mark PCI’s fifth acquisition outside of the U.S. in five years US firm PCI Pharma Services (PCI) has announced the acquisition of Australia-...
20 February 2018 Asia Pacific | Australasia | news | North America
Continue Reading →
Australasia

DIMERIX Ltd, Dimerix to Present Analysis of DMX-200 Phase 2a Clinical Trial in Chronic Kidney Disease at the American Society of Nephrology (ASN) Annual Kidney Week 2017

Dimerix Limited (ASX: DXB), is pleased to announce that a detailed analysis of the data from the DMX-200 Phase 2a clinical trial in Chronic Kidney Disease will be ...
16 August 2017 Australasia | news
Continue Reading →
Australasia

MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test

RVINE, CA, and HERSTAL, BELGIUM - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a scientific agreement with QUT bluebox, the commercialization ...
21 June 2017 Australasia | news | Regional News
Continue Reading →
Australasia

PCI Pharma Services Showcasing Serialization Expertise at Pharmapack Europe in Paris

Philadelphia, USA – February 1st, 2016. Visitors to Pharmapack Europe will gain more insight to the fast-changing world of Serialization with the expert team from lea...
2 February 2016 Australasia | Regional News
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte